Delving into the Latest Updates on Becro Ltd. with Synapse

Overview

Non-inferiority Clinical Trial for Comparing the Efficacy and Tolerability of a new fixed-Combination Generic Formulation of Brimonidine 0.2%/Timolol 0.5% eye drops, solution in single-dose containers vs Combigan® eye drops, solution in Patients with Open Angle Glaucoma or Ocular Hypertension - BECRO/PS/ETHRA

Start Date13 Jun 2024

Sponsor / Collaborator

Becro Ltd.

NCT06025214

/ RecruitingPhase 1

A Randomized, Single-dose, Open Label, Two-treatment, Two-sequence, Two-period, Crossover Study Under Fasting Conditions to Examine the Bioequivalence Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence study between two inhaler products of fixed dose combination of fluticasone propionate and salmeterol xinafoate inhalation powder

Start Date22 Aug 2023

Sponsor / Collaborator

Respirent Pharmaceuticals Co. Ltd.

[+1]

NCT05982990

/ Active, not recruitingPhase 1

A Randomized, Single-dose, Open Label, Two-treatment, Two-sequence, Two-period, Crossover Study Under Fasting Conditions to Examine the Bioequivalence Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Bioequivalence study between two inhaler products of fixed dose combination of fluticasone propionate and salmeterol xinafoate inhalation powder

Start Date01 Aug 2023

Sponsor / Collaborator

Respirent Pharmaceuticals Co. Ltd.

[+1]

100 Clinical Results associated with Becro Ltd.

Login to view more data

0 Patents (Medical) associated with Becro Ltd.

Login to view more data

100 Deals associated with Becro Ltd.

Login to view more data

100 Translational Medicine associated with Becro Ltd.